Effect of a Very Low Calorie and Low Calorie Diet on Moderate to Severe Obstructive Sleep Apnea in Obese Adults

NCT ID: NCT02251574

Last Updated: 2018-04-05

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

37 participants

Study Classification

INTERVENTIONAL

Study Start Date

2014-09-30

Study Completion Date

2016-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to test the effectiveness of two different weight loss diets on obstructive sleep apnea (OSA) severity.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Sleep apnea is a sleep disorder in which breathing repeatedly stops and starts during sleep. The most common type is obstructive sleep apnea (OSA), which occurs when the muscles in your throat relax and block your airway during sleep. The most noticeable sign of OSA is snoring. OSA is a risk factor for other chronic conditions like type 2 diabetes, cardiovascular disease, and high blood pressure.

Although anyone can develop OSA, it commonly affects people who are obese. The more someone weighs, the more likely the OSA is to be severe. Weight loss is typically recommended for overweight individuals to help improve OSA. However, not enough research has been done for doctors to be able make specific recommendations to their patients.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Obstructive Sleep Apnea

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Low Calorie Diet

Participants will take part in an experimental weight management program involving a low calorie diet (LCD), about 1200-1500 calories per day.

Group Type EXPERIMENTAL

Low Calorie Diet

Intervention Type OTHER

Weight management program designed around a low calorie diet.

Very Low Calorie Diet

Participants will take part in an experimental weight management program involving a low calorie diet (LCD), about 520-800 calories per day.

Group Type EXPERIMENTAL

Very Low Calorie Diet

Intervention Type OTHER

Weight management program designed around a very low calorie diet.

Standard Care

Participants will receive normal care.

Group Type ACTIVE_COMPARATOR

Standard Care

Intervention Type OTHER

Care provided that would normally be given to people meeting eligibility criteria for this study.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Low Calorie Diet

Weight management program designed around a low calorie diet.

Intervention Type OTHER

Very Low Calorie Diet

Weight management program designed around a very low calorie diet.

Intervention Type OTHER

Standard Care

Care provided that would normally be given to people meeting eligibility criteria for this study.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* AHI score of ≥ 5
* Body mass index (BMI) between 30 to 49.9 kg/m2

Exclusion Criteria

* Report serious medical risk such as insulin-dependent diabetes, active cancer, recent cardiac event
* Currently or planning to become pregnant during the next 9 months
* Not weight stable (-4.6 kg) for 3 mos. prior to intake
* Report current participation in a weight reduction program involving diet or PA
* Unwilling to be randomized to 1 of 3 study groups
* Report symptomology of an eating disorder as determined by the Eating Attitudes Test
* Unable to participate in moderate intensity physical activity
Minimum Eligible Age

21 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Kansas Medical Center

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jeannine Goetz, PhD

Role: PRINCIPAL_INVESTIGATOR

University of Kansas Medical Center

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Kansas Medical Center

Kansas City, Kansas, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

STUDY00001418

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Fat Metabolism in OSA and COPD
NCT02157844 COMPLETED
Time Restricted Eating in Sleep Apnea
NCT06047496 RECRUITING EARLY_PHASE1
Low-Tech Treatments for Obstructive Sleep Apnea
NCT07301710 NOT_YET_RECRUITING PHASE1/PHASE2
Metabolism and Sleep Apnea Treatment
NCT05539716 RECRUITING NA
Impact of Exogenous Ketones on Sleep Apnea
NCT06687655 NOT_YET_RECRUITING PHASE1/PHASE2